|
⚲
|
| Keyboard |
| Defilade Capital Management LP
✚
|
|
|---|---|
| CRD # | 337997 |
| SEC # | 801-134248 |
| CIK # | 0002088557 |
| AUM | 1,548.6 M (2026-06-26) |
| Employees | 7 (71% Investors, 0% Brokers) |
| Fees | |
| Minimum | |
| Phone | 415-849-9478 |
| Address | 6001 Shellmound Street Emeryville, CA 94608 |
| Source | [IAPD] [EDGAR] [Website] |
| Total AUM ($M) |
|---|
| CIK | Period |
|---|---|
| 0002088557 |
| Sector | Form 13F Holdings | Value ($M) |
|---|---|---|
| Zimmer Holdings Inc | 52.4 | |
| Henry Schein Inc | 46.0 | |
| Becton Dickinson & Co | 43.9 | |
| Pfizer Inc | 41.1 | |
| Dexcom Inc | 33.8 | |
| ICU Medical Inc/DE | 32.8 | |
| Insmed Inc | 31.9 | |
| Intuitive Surgical Inc | 31.2 | |
| Revolution Medicines Inc | 30.7 | |
| Globus Medical Inc | 30.5 | |
| Neurocrine Biosciences Inc | 27.7 | |
| Denali Therapeutics Inc | 26.1 | |
| PTC Therapeutics Inc | 25.6 | |
| Olema Pharmaceuticals Inc | 22.4 | |
| Elanco Animal Health Inc | 22.3 | |
| PACS Group Inc | 19.4 | |
| Lilly Eli & Co | 19.0 | |
| Lantheus Holdings Inc | 18.9 | |
| Greatbatch Inc | 18.7 | |
| Biogen IDEC Inc | 17.7 | |
| Evommune Inc | 15.6 | |
| Tandem Diabetes Care Inc | 14.6 | |
| UNUM Therapeutics Inc | 13.6 | |
| Nuvalent Inc | 13.3 | |
| Ocular Therapeutix Inc | 12.6 | |
| Ascendis Pharma A/S | 11.9 | |
| Align Technology Inc | 11.5 | |
| Tokai Pharmaceuticals Inc | 11.0 | |
| Oric Pharmaceuticals Inc | 10.7 | |
| Biohaven Ltd | 2.7 | Prev | Page 1 | Next |
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| HF | Defilade Capital Master Fund LP | [2025-12-22] | 1,548.6 M | |
| Filed 2025-08-27 (D) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 3 | 1,548.6 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 3 | 1,548.6 |
| By Discretionary | ||
| Discretionary | 3 | 1,548.6 |
| Non-Discretionary | 0 | 0.0 |
| Total | 3 | 1,548.6 |
| By Non-United States Persons | ||
| Non-United States Persons | 439.3 | |
| United States Persons | 1,109.3 | |
| Total | 3 | 1,548.6 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Defilade Capital Management LP | Promoter | 2 | 2 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0002088557] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Fund Types | Hedge Fund |
| Comparable Firms | State | AUM |
|---|---|---|
|
Hercules Adviser LLC
✚
|
CA | 1,558.0 M |
|
Oak Thistle LLC
✚
|
1,554.0 M | |
|
Gladstone Capital Management LLP
✚
|
1,552.2 M | |
|
GAM USA Inc
✚
|
NY | 1,547.2 M |
|
Red Cliff Asset Management Limited
✚
|
1,545.2 M | |
|
Camelot Capital Partners LLC
✚
|
CA | 1,540.9 M |
|
Greenbrier Partners Capital Management LLC
✚
|
TX | 1,540.6 M |
|
Graticule Asset Management Asia PTE Ltd
✚
|
1,539.1 M | |
|
Graticule Asia Macro Advisors LLC
✚
|
1,536.9 M | |
|
Meteora Capital LLC
✚
|
FL | 1,536.0 M |